Sierra Capital LLC Gilead Sciences, Inc. Transaction History

Sierra Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$57.72 - $65.01 $4,155 - $4,680	-72 Reduced 7.25%	921 $57,000
Q1 2022 May 03, 2022	SELL	$57.92 - $72.58 $347 - $435	-6 Reduced 0.6%	993 $59,000
Q4 2021 Feb 10, 2022	BUY	$64.88 - $73.64 $5,060 - $5,743	78 Added 8.47%	999 $73,000
Q1 2021 May 28, 2021	BUY	$60.0 - $68.46 $55,260 - $63,051	921 New	921 $59,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Sierra Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Sierra Capital LLC with notifications on news.